NeurAxon distribution expanded

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p10
Trade Publication
The article reports on the expansion of the distribution of NeurAxon, a pharmaceutical grade dietary supplement for brain function, by Ferrer Therapeutics Inc. in the U.S.


Related Articles

  • Ferrer Therapeutics.  // Chain Drug Review;1/17/2011, Vol. 33 Issue 2, p41 

    The article offers brief information on the NeurAxon dietary supplement from Ferrer Therapeutics Inc.

  • The incredible thinking industry. Chase, James // Medical Marketing & Media;May2011, Vol. 46 Issue 5, p6 

    An introduction to the journal is presented wherein the author discusses the topics to be addressed at the Virtual Summit on May 24, 2011 which focus on the pharmaceutical industry in the U.S.

  • REPORTERS Notebook.  // Drug Store News;2/7/2011, Vol. 33 Issue 2, p28 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including the approval of Watson Pharmaceuticals Inc.'s generic drug by the Food and Drug Administration (FDA), the development of biosimilars by Merck & Co. Inc. and the launch of MyEpiPenn, a smart phone...

  • Clinical Briefs. Kuritzky, Louis // Internal Medicine Alert;1/29/2010, Vol. 32 Issue 2, p16 

    The article offers news briefs related to pharmaceutical industry in the U.S. in 2010.

  • MED ED REPORT: Update.  // Medical Marketing & Media;Apr2011, Vol. 46 Issue 4, p19 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including Informed Medical Communications merged with IC Axon, Prime-Med Point of Care launched the website www.pri-medpointofcare.com, and PDI launched its EngageCE division.

  • Three Things.  // Pharmaceutical Representative;Sep2011, Vol. 41 Issue 9, p9 

    The article offers updates in the pharmaceutical industry of the U.S. including the cuts on research & development in Lundbeck Research USA, the use of iPad or tablet computers by physicians, and the spurring of debt-ceiling deals in the industry.

  • Pharma spends big to buy influence.  // Nature Medicine;Mar2010, Vol. 16 Issue 3, p243 

    The article reports on the 267 million dollars spent by the pharmaceutical and health products industry on lobbying efforts in the U.S. in 2009.

  • NEWS BYTES.  // Drug Store News;4/19/2010, Vol. 32 Issue 5, p6 

    The article offers news briefs in the U.S. pharmaceutical industry including the appointment of C. Daniel Haron as president of Cigna Pharmacy Management, the 5.3% rise of the fourth quarter sales of Duane Reade, and the 2.4% revenue drop at Rite Aid.

  • NEWS BYTES.  // Drug Store News;10/11/2010, Vol. 32 Issue 12, p6 

    The article presents news briefs related to the pharmaceutical industry in the U.S. including decline in revenue for Rite Aid and appointment of Scott Melville as the president of Consumer Healthcare Products Association.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics